• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE Back to Search Results
Model Number SIG45CTAMT
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Laceration(s) (1946); Tissue Breakdown (2681)
Date of Event 02/19/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during a video-assisted thoracoscopic surgery, immediately after firing, the surgeon left the visual field of the sectioned bronchus and retired some ganglions.When the surgeon was back to the field of the bronchus, the staple line have become opened.This led to the conversion to an open surgery, extending surgical time by 60 minutes, and requiring suturing as a replacement for the staple line.The patient needed extended hospitalization and was admitted to the intensive care unit.
 
Additional Manufacturer Narrative
Additional information:g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was not returned, but photos were available for evaluation.Visual inspection noted that the two of the photos showed the staple line in the patient.One staple was visible and appeared to be properly formed in the tissue.Three of the photos showed the used reload.The reload was fully fired.At the proximal end of the jaws, fully formed staples were present in the cartridge.The middle section of the cartridge had flush pushers, where as the pushers on the distal end were fully proud.It was reported that during a video-assisted thoracoscopic surgery, the staple line opened.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRI-STAPLE 2.0
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer (Section G)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer Contact
mike bocchino
8200 coral sea st ne
mounds view, MN 55112-4391
8006464633
MDR Report Key24551872
Report Number1219930-2026-01543
Device Sequence Number18488232
Product Code GDW
UDI-Device Identifier10884521543713
UDI-Public(01)10884521543713(17)300131(10)N5B1544Y(20)03
Combination Product (Y/N)N
Initial Reporter CountryPO
PMA/510(K) Number
K160176
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSIG45CTAMT
Device Catalogue NumberSIG45CTAMT
Device Lot NumberN5B1544Y
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/23/2026
Supplement Date Received by Manufacturer05/14/2026
Initial Report FDA Received Date03/09/2026
Supplement Report FDA Received Date05/23/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age69 YR
Patient SexMale
-
-